The makers of Rituxan® (rituximab) have the following programs to help you get the treatment you need.
THE GENENTECH RHEUMATOLOGY CO-PAY CARD PROGRAM*
This program allows eligible commercially insured patients to pay $5 per Rituxan co-pay. The card is valid for up to $15,000 of co-pay assistance within a 12-month period. Additional terms and conditions apply.*
To find out if you are eligible for any of our programs, please use the tool below or call 1-855-RA-COPAY (1-855-722-6729) to talk with a specialist.
To find out the right program for you, use the tool below.
Genentech Rheumatology Co-pay Card Program
This program might be able to help reduce out-of-pocket expenses associated with your prescription.
Co-pay Assistance Foundations
If you need help with medication co-pays, we can refer you to co-pay assistance foundations. Foundations have their own specific criteria.
The Genentech® Access to Care Foundation, or GATCF
GATCF helps qualified patients receive their medicine free of charge. To qualify for free medicine from GATCF, you need to meet specific medical and financial criteria.
*The Genentech Rheumatology Co-pay Card Program is not a benefit plan. This program helps with your costs described as “out-of-pocket,” “co-pay,” “co-insurance,” or “uncovered expense” for Rituxan only. It does not pay for other costs related to your visit or infusion. Genentech and Biogen reserve the right to change or end this program. This may be done in whole or in part, without notice, at any time.
Genentech Rheumatology Co-pay Card Program Terms and Conditions
By using the Genentech Rheumatology Co-pay Card program, the patient acknowledges and confirms that at the time of usage, (s)he is currently eligible and meets the criteria set forth in the terms and conditions described.
This Co-pay Card is valid ONLY for patients with commercial (private or nongovernmental) insurance. It is not valid for patients who are government beneficiaries or whose medications are covered, in whole or in part, under Medicaid; Medicare Part A, B, C and/or D; TRICARE; CHAMPUS; Puerto Rico Government Health Insurance Plan or any other state or federal health care program. Patients who become government beneficiaries during their enrollment period will no longer be eligible for the program as of the date they become a government beneficiary.
The Genentech Rheumatology Co-pay Card program is not health insurance or a benefit plan. Distribution or use of the Co-pay Card does not obligate use or continuing use of any specific product or provider. Patient or guardian is responsible for reporting the receipt of all Genentech Rheumatology Co-pay Card program benefits or reimbursement received, to any insurer, health plan or other third party who pays for or reimburses any part of the prescription filled using the Genentech Rheumatology Co-pay Card program, as may be required.
The Co-pay Card is not valid for medications the patient receives for free or that are eligible to be reimbursed by private insurance plans or other health care or pharmaceutical assistance programs (such as: GATCF or any other charitable organization) that reimburse the patient in part or for the entire cost of his/her medication. Patient, guardian, pharmacist, prescriber and any other person using the Co-pay Card agree not to seek reimbursement for all or any part of the benefit received by the recipient through the offer.
The Co-pay Card will be accepted by participating pharmacies, physician offices or hospitals. To qualify for the benefits of the Genentech Rheumatology Co-pay Card program, the patient may be required to pay out-of-pocket expenses for each treatment. Once enrolled, the Genentech Rheumatology Co-pay Card program will not honor claims with date of service or medication dispensing that precede Genentech Rheumatology Co-pay Card program enrollment by more than 120 days. This Co-pay Card is only available with a valid prescription and cannot be combined with any other rebate/coupon, free trial or similar offer for the specified prescription. Use of this Co-pay Card must be consistent with all relevant health insurance requirements and payer agreements. Participating patients, pharmacies, physician offices and hospitals are obligated to inform third-party payers about the use of the Co-pay Card as provided for under the applicable insurance or as otherwise required by contract or law. The Co-pay Card may not be sold, purchased, traded or offered for sale, purchase or trade. The Co-pay Card is limited to 1 per person during this offering period and is not transferable. The Genentech Rheumatology Co-pay Card program expires within 12 months from enrollment. The Genentech Rheumatology Co-pay Card program is not valid where prohibited by law. For Massachusetts’ residents, the Co-pay Card is not valid for any prescription drug that has an AB rated generic equivalent as determined by the United States Food and Drug Administration. For Massachusetts’ residents, the Genentech Rheumatology Co-pay Card program shall expire on or before July 1, 2017.
The patient or their guardian must be 18 years or older to receive Genentech Rheumatology Co-pay Card program assistance. The Genentech Rheumatology Co-pay Card program is: (1) void if the card is reproduced; (2) void where prohibited by law; (3) only valid in the United States and Puerto Rico; and (4) only valid for Genentech products. Health care providers may not advertise or otherwise use the program as a means of promoting their services or Genentech’s products to patients. Genentech, Inc. reserves the right to rescind, revoke or amend the program without notice at any time.